Regulations.gov document
Determination That LEVOTHROID (Levothyroxine Sodium) Tablets, 0.025 Milligram, 0.05…
Notice · FDA-2015-P-0403 · posted May 31, 2016
Key facts
| Document ID | FDA-2015-P-0403-0007 |
|---|---|
| Title | Determination That LEVOTHROID (Levothyroxine Sodium) Tablets, 0.025 Milligram, 0.05 Milligram, 0.075 Milligram, 0.088 Milligram, 0.112 Milligram, 0.125 Milligram, 0.137 Milligram, 0.15 Milligram, 0.175 Milligram, 0.1 Milligram, 0.2 Milligram, and 0.3 Milligram, Were Not Withdrawn From Sale for Reasons of Safety or Effectiveness |
| Document type | Notice |
| Subtype | Determinations |
| Agency | FDA |
| Docket | FDA-2015-P-0403 |
| Posted | May 31, 2016 |
| Federal Register citation | 81 FR 34347 |
| FR document number | 2016-12655 |
| Comment period opens | May 31, 2016 |
| Effective date | May 31, 2016 |
At a glance
- 1–9 Pages
- None Public comments on this docket
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Regulations.gov documents
Regulations.gov holds the rulemaking and other documents federal agencies post for public comment. Only agency documents are published here; public submissions are not.
Source: Regulations.gov (U.S. General Services Administration eRulemaking Program) · Source date: